Catalio Capital Management to Sell Minority Stake to KKR

Paul, Weiss is advising Catalio Capital Management, LP, a multi-strategy investment firm focused on breakthrough biomedical technology and innovative health care companies, in its sale of a minority stake to leading global investment firm KKR. Under the terms of the agreement, KKR will also invest in Catalio’s funds and KKR co-founder and Executive Chairman Henry Kravis will be named chair of Catalio’s new board of advisors. The addition of new capital is expected to accelerate Catalio’s growth trajectory and talent acquisition, as well as anchor its investment strategies. Financial terms of the transaction were not disclosed.

The Paul, Weiss team is led by corporate partners Michael Vogel and Udi Grofman, and includes corporate partner Aaron Schlaphoff, counsel Erika Detjen, Matthew Zweig, Allison Muth, Arik Hirschfeld and Jennifer Songer; tax partners Brian Krause and Patrick Karsnitz and counsel Anne McGinnis; executive compensation partner Lawrence Witdorchic and counsel Jake Glazeski; litigation partner Gregory Laufer and counsel Steven Herzog; and intellectual property counsel Elana Bensoul.